Lee, Yen-ChiehYen-ChiehLeeCHIA-HSUIN CHANGDong, Yaa-HuiYaa-HuiDongJOU-WEI LINWu, Li-ChiuLi-ChiuWuHwang, Jing-ShiangJing-ShiangHwangLEE-MING CHUANG2022-12-302022-12-302017-02-010167-5273https://scholars.lib.ntu.edu.tw/handle/123456789/626874Increasing evidence suggests that certain newer anti-diabetic drugs are associated with an increased risk of hospitalized heart failure (HHF). However, the potential risks associated with the use of sulfonylurea and glinide have not been carefully evaluated.enAcarbose; Glinides; Heart failure; Sulfonylurea[SDGs]SDG3Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide studyjournal article10.1016/j.ijcard.2016.11.022279232072-s2.0-85002045820WOS:000393408600157https://api.elsevier.com/content/abstract/scopus_id/85002045820